• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOLOGIC, INC NOVASURE; DEVICE, THERMAL ABLATION, ENDOMETRIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOLOGIC, INC NOVASURE; DEVICE, THERMAL ABLATION, ENDOMETRIAL Back to Search Results
Model Number V5
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Uterine Perforation (2121)
Date of Event 06/05/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
A device history record (dhr) review was conducted for the reported lot/serial number.The device was released meeting all qa specifications.The device involved in this event was not returned for evaluation purposes therefore visual and functional analysis of the product could not be performed.We are unable to confirm a relationship between the device and the issue reported.The information obtained during complaint investigation will be included in our global complaint trending and product surveillance will continue to monitor complaints of this type for adverse trends.If the product is received or additional information is obtained, the investigation will be reopened accordingly per standard operating procedure.
 
Event or Problem Description
It was reported that during a novasure procedure on (b)(6) 2025, the physician was not able to pass initial cavity integrity assessment.Checked the cavity with a hysteroscope and nothing looked irregular.Exchanged the device for a new one and was still unable to pass the cavity initial assessment.They looked at the cavity a second time and noticed a uterine perforation for which at this point aborted the procedure.Patient was discharged and was doing great and stable.The provided notified that the patient will be scheduled for a complete hysterectomy.No other information available.
 
Additional Manufacturer Narrative
Device was returned for investigation: visual inspection was conducted and there were no signs of physical damage.Functional test was conducted and the device passed the testing.In addition, there is no sharp edges in the array.No causality could be established between the device and the uterine perforation; the event is related to usage of the device.This observation will be monitored and trended.A device history record (dhr) review was conducted for the reported lot/serial number.The device was released meeting all qa specifications.We are currently unable to establish a relationship between the device and the issue reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NOVASURE
Common Device Name
DEVICE, THERMAL ABLATION, ENDOMETRIAL
Manufacturer (Section D)
HOLOGIC, INC
250 campus drive
marlborough MA 01752
Manufacturer (Section G)
HOLOGIC, INC.
250 campus drive
marlborough MA 01752
Manufacturer Contact
daniel guevara
562 parkway
coyol free park zone b24
alajuela 20102
MDR Report Key22328258
Report Number1222780-2025-00341
Device Sequence Number8429775
Product Code MNB
UDI-Device Identifier15420045514294
UDI-Public(01)15420045514294(17)250617(10)23E29RQ
Combination Product (Y/N)N
Initial Reporter StateWI
Initial Reporter CountryUS
PMA/510(K) Number
P010013
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source User Facility,Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 08/04/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date06/17/2025
Device Model NumberV5
Device Catalogue NumberNSV5US-001
Device Lot Number23E29RQ
Was Device Available for Evaluation? Device Returned to Manufacturer
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/05/2025
Supplement Date Received by Manufacturer07/14/2025
Initial Report FDA Received Date06/25/2025
Supplement Report FDA Received Date08/04/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured05/29/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Other;
Patient SexUnknown
-
-